Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DTC Brief Summary: Consumers Prefer Q&A Format Over Others

Executive Summary

Consumers prefer direct-to-consumer print ad brief summaries that appear in a question-and-answer form, a study by University of Georgia Professor Matthew Perri, PhD, indicates

You may also be interested in...



FDA Research Protocols On DTC Brief Summary Info To Be Finalized In Fall

FDA expects to finalize internal protocols this fall for agency-conducted studies on the brief summary information in direct-to-consumer ads

FDA Research Protocols On DTC Brief Summary Info To Be Finalized In Fall

FDA expects to finalize internal protocols this fall for agency-conducted studies on the brief summary information in direct-to-consumer ads

Risk Information “Window” Proposed By FDA For DTC Print Ads

A "risk information window" with bullet points is being proposed by FDA as an alternative to presentation of adverse events and warnings in the text of prescription drug direct-to-consumer ads

UsernamePublicRestriction

Register

LL1135645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel